SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-038831
Filing Date
2018-06-20
Accepted
2018-06-20 17:47:46
Documents
1
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5777
  Complete submission text file 0001209191-18-038831.txt   7104
Mailing Address 4611 UNIVERSITY DR 4 UNIVERSITY PLACE DURHAM NC 27707
Business Address
WELCH DANIEL G (Reporting) CIK: 0001206199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 18910317

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations